Details of the Drug
General Information of Drug (ID: DM4FJHO)
Drug Name |
(5-Methoxy-chroman-3-yl)-dipropyl-amine
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
5-Meo-dpac; 5-Methoxy-3-(di-n-propylamino)chroman; CHEMBL283606; 3-Dipropylamino-5-methyloxychroman; 5-Methoxy-3-(dipropylamino)chroman; (5-Methoxy-chroman-3-yl)-dipropyl-amine; AC1MIZ4R; 110927-00-9; SCHEMBL2217080; CTK8G5655; GOWYIQOIWRLZLO-UHFFFAOYSA-N; BDBM50036862; 3-(Di-n-propylamino)-5-methoxychroman; L023817; 5-methoxy-N,N-dipropyl-3,4-dihydro-2H-chromen-3-amine; 5-methoxy-3,4-dihydro-N,N-dipropyl-2H-[1]-benzopyran-3-amine; 2H-1-Benzopyran-3-amine, 3,4-dihydro-5-methoxy-N,N-dipropyl-
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 263.37 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 3.8 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 6 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||